ESH MM 2018 | Real world data: bortezomib-based therapy for R/R myeloma
Evangelos Terpos, MD, PhD, of the University of Athens, Athens, Greece, discusses real world data on the use of bortezomib for relapsed/refractory multiple myeloma (MM). Dr Terpos highlights the importance of these results, particularly in cases where newer drugs are not available. This interview was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
Get great new content delivered to your inboxSign up